XML 60 R46.htm IDEA: XBRL DOCUMENT
v3.23.3

Commitments and Contingencies - Medytox Litigation (Details) - USD ($) $ / shares in Units, $ in Millions |  |  | 1 Months Ended |  |  |  |
--- | --- | --- | --- | --- | --- | --- | ---
Jun. 28, 2021 | Jun. 21, 2021 | Jun. 30, 2021 | Jun. 30, 2023 | Mar. 31, 2023 | Dec. 31, 2022 | Dec. 31, 2021
Commitments and Contingencies |  |  |  |  |  |  |
Common stock, par value |  |  |  | $ 0.0001 | $ 0.0001 | $ 0.0001 | $ 0.0001
Medytox Litigation |  |  |  |  |  |  |
Commitments and Contingencies |  |  |  |  |  |  |
Issuance of common stock in connection with litigation settlement | 26,680,511 | 26,680,511 |  |  |  |  |
Common stock, par value |  | $ 0.0001 |  |  |  |  |
Term for payments of royalties on net sales of licensed products |  | 15 years |  |  |  |  |
Threshold product sale for payments of royalties |  | $ 1.0 |  |  |  |  |
Target ownership |  | 10.00% |  |  |  |  |
Litigation settlement |  |  | $ 29.0 |  |  |  |

X
- Definition Represents the target ownership that would be calculated on the earlier of the Company's initial public offering or the conversion of the Company's preferred stock into common stock. + References No definition available. + Details
Name: | aeon_LitigationSettlementTargetOwnership
Namespace Prefix: | aeon_
Data Type: | dtr-types:percentItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the term for payments of royalties on net sales of licensed products. + References No definition available. + Details
Name: | aeon_LitigationSettlementTermForPaymentsOfRoyaltiesOnNetSalesOfLicensedProducts
Namespace Prefix: | aeon_
Data Type: | xbrli:durationItemType
Balance Type: | na
Period Type: | duration

X
- Definition Represents the threshold product sale for payments of royalties. + References No definition available. + Details
Name: | aeon_LitigationSettlementThresholdProductSaleForPaymentsOfRoyalties
Namespace Prefix: | aeon_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Represents the number of common stock issued for litigation settlement during the period. + References No definition available. + Details
Name: | aeon_StockIssuedDuringPeriodSharesLitigationSettlement
Namespace Prefix: | aeon_
Data Type: | xbrli:sharesItemType
Balance Type: | na
Period Type: | duration

X
- Definition Face amount or stated value per share of common stock. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02(29)) -URI https://asc.fasb.org/extlink&oid=120391452&loc=d3e13212-122682 + Details
Name: | us-gaap_CommonStockParOrStatedValuePerShare
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:perShareItemType
Balance Type: | na
Period Type: | instant

X
- Definition Amount awarded to other party in judgment or settlement of litigation. + References No definition available. + Details
Name: | us-gaap_LitigationSettlementAmountAwardedToOtherParty
Namespace Prefix: | us-gaap_
Data Type: | xbrli:monetaryItemType
Balance Type: | credit
Period Type: | duration

X
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. + References No definition available. + Details
Name: | us-gaap_LossContingenciesLineItems
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Details
Name: | srt_LitigationCaseAxis=aeon_MedytoxLitigationMember
Namespace Prefix: |
Data Type: | na
Balance Type: |
Period Type: |